Embla Medical hf.
OSSFF
$4.15
$0.071.72%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.61% | -9.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.61% | -9.79% | |||
| Cost of Revenue | 17.21% | -9.25% | |||
| Gross Profit | 13.09% | -10.10% | |||
| SG&A Expenses | 4.21% | -3.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.06% | -6.17% | |||
| Operating Income | 52.29% | -31.59% | |||
| Income Before Tax | 76.74% | -37.07% | |||
| Income Tax Expenses | 80.69% | -42.02% | |||
| Earnings from Continuing Operations | 75.54% | -35.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -254.96% | 131.72% | |||
| Net Income | 71.98% | -33.21% | |||
| EBIT | 52.29% | -31.59% | |||
| EBITDA | 47.14% | -27.58% | |||
| EPS Basic | 78.57% | -36.36% | |||
| Normalized Basic EPS | 79.39% | -37.70% | |||
| EPS Diluted | 78.57% | -36.36% | |||
| Normalized Diluted EPS | 79.39% | -37.70% | |||
| Average Basic Shares Outstanding | -3.69% | 4.94% | |||
| Average Diluted Shares Outstanding | -3.69% | 4.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||